Epidermal growth factor receptor tyrosine Kinase inhibitor treatment response in advanced lung adenocarcinomas with G719X/L861Q/S768I mutations

Chao Hua Chiu, Cheng Ta Yang, Jin Yuan Shih, Ming Shyan Huang, Wu Chou Su, Ruay Sheng Lai, Chin Chou Wang, Shih Hsin Hsiao, Yu Ching Lin, Ching Liang Ho, Te Chun Hsia, Ming Fang Wu, Chun Liang Lai, Kang Yun Lee, Chih Bin Lin, Diana Yu-Wung Yeh, Chi Yuan Chuang, Fu Kang Chang, Chun Ming Tsai, Reury Perng PerngJames Chih-Hsin Yang

Research output: Contribution to journalArticlepeer-review

222 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Epidermal growth factor receptor tyrosine Kinase inhibitor treatment response in advanced lung adenocarcinomas with G719X/L861Q/S768I mutations'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science